Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
The VITA-FAST tokens have been met with overwhelming interest
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Construction will begin this year with the new capacity anticipated by 2025
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Getinge has a strong market share in India within several product segments
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
Subscribe To Our Newsletter & Stay Updated
